Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ASTH · against 386 other Healthcare companies of similar size
Ranked #40 of 387 · scores higher than 89% of peers
Bars: peers in each 10-point band of the growth score46 peers with a growth score of 80–89, including ASTH · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
| Metric | ASTH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 389 reported | 58.9% | 6.2% | 93% | 33% | |
| Earnings per share growthHigher is better · 219 reported | 31.8% | 8.3% | 71% | 33% | |
| 3-year revenue growthHigher is better · 380 reported | 43.7% | 7.3% | 92% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 40 | 18.7B CNY (≈$2.6B) | 89 | 51 | |
| 40 | 6.8B CNY (≈$959M) | 89 | 43 | |
| 40 | 2.4B EUR (≈$2.6B) | 89 | 69 | |
| 40 | 1.7B USD | 89 | 77 | |
| 40 | 1.8B USD | 89 | 52 | |
| 40 | 2.2B USD | 89 | 32 | |
| 46 | 2.4B SGD (≈$1.8B) | 88 | 79 | |
| 46 | 1.5B AUD (≈$982M) | 88 | 54 | |
| 46 | 913M USD | 88 | 77 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score